Clinical Trial Update: A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV) [Phase 1]

View source ↗

Summary

Phase 1 study of a new candidate hepatitis C vaccine sponsored by ReiThera Srl has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HCV vaccine candidate

Snippet

Sponsor: ReiThera Srl | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED